Pelvic Congestion Syndrome: Evaluation and Management
In reproductive-age multiparous women with chronic dull pelvic pain worsening with standing or menses, proceed directly to transvaginal Doppler ultrasound to detect venous reflux in ovarian/uterine veins, followed by MRI for detailed venous anatomy assessment, and treat with ovarian vein embolization as first-line therapy when imaging confirms pelvic venous insufficiency 1, 2.
Diagnostic Approach
Initial Imaging Strategy
Start with transvaginal Doppler ultrasound as your primary screening tool—it is non-invasive, sensitive, and specifically detects venous reflux in the ovarian and uterine veins that characterize this condition 1, 2. This should be your first-line imaging, not a "comprehensive workup."
Follow positive ultrasound findings with MRI for detailed assessment of venous anatomy 1. The MRI provides the anatomical detail needed to plan intervention and exclude other causes of chronic pelvic pain.
Invasive Diagnosis When Intervention is Planned
Trans-catheter venography with IVUS remains the gold standard and should be performed immediately before planned embolization 3. The 2024 consensus guidelines specify that when evaluating for associated nonthrombotic iliac vein lesions (NIVL), you must use dynamic IVUS evaluation with breath-hold maneuvers and increased intra-abdominal pressure 4. Only proceed with iliac vein stenting if IVUS shows >50% area reduction or >61% diameter stenosis—intervention below these thresholds is not recommended 4.
Key Clinical Features to Identify
Look specifically for:
- Chronic pelvic pain >6 months duration
- Pain worse with prolonged standing, walking, and pre-menstrual period
- Post-coital ache, dyspareunia, dysmenorrhea
- Bladder irritability and rectal discomfort
- Vulval varicosities or lower limb venous pathology 3, 2
The typical patient is multiparous and of reproductive age 3, 2.
Treatment Algorithm
Primary Treatment: Ovarian Vein Embolization
Ovarian vein embolization (OVE) is your first-line definitive treatment 1, 3, 2. The evidence strongly supports this approach:
- Technical success rates: 96-100%
- Long-term symptomatic relief: 70-90% of cases
- Low complication rates 3
This has superseded conservative, medical, and surgical management strategies 3.
When Iliac Vein Pathology Coexists
Critical clinical decision point: When both gonadal vein reflux AND nonthrombotic iliac vein lesions are present, the 2024 consensus data shows that combined treatment (iliac vein stenting plus ovarian vein embolization) provides superior symptom relief compared to OVE alone 4. This can be performed simultaneously or staged 4.
However, only treat the iliac vein component if IVUS criteria are met (>50% area reduction or >61% diameter stenosis) 4.
Treatment Sequence
- Confirm diagnosis with transvaginal Doppler ultrasound and MRI
- Perform venography with IVUS immediately before planned intervention
- Embolize ovarian veins as primary treatment
- Add iliac vein stenting only if IVUS demonstrates significant stenosis (>50% area or >61% diameter) 4, 1
Important Clinical Pitfalls
Underdiagnosis is the primary problem—average time to diagnosis is up to 4 years after initial presentation 2. PCS accounts for nearly one-third of chronic pelvic pain cases when nongynecologic causes are considered, yet it remains poorly recognized 4, 3.
Do not rely on venography thresholds alone for diagnosis and treatment decisions—IVUS is essential for accurate assessment 4.
Avoid treating dynamic iliac vein compressions—fixed lesions on IVUS are pathological, while compressions that vary with maneuvers are less likely to be clinically significant 4.
The lack of prospective, multicenter randomized controlled trials remains a barrier to complete acceptance of diagnostic and treatment protocols, but the existing evidence consistently supports the endovascular approach 3, 5.